Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.91 | N/A | +1.90% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.91 | N/A | +1.90% |
| Revenue | N/A | N/A | N/A |
Tone: Neutral
Management acknowledged the competitive landscape affecting performance. They reiterated their commitment to improving operational efficiencies.
Management highlighted ongoing challenges in the retail environment.
They emphasized a focus on cost management and operational efficiency.
No specific guidance was provided for the upcoming quarter.
Prestige Consumer HE reported a slight earnings beat, but the stock fell by over 3% in response. Investors may be concerned about the lack of revenue details and guidance, indicating uncertainty about future performance. The management's cautious tone suggests ongoing challenges in the retail sector, which could impact growth moving forward.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ENTERPRISE PRODS PAR
May 2, 2022